Monoclonal Antibody against Leukocyte Common Antigen
产品名称: Monoclonal Antibody against Leukocyte Common Antigen
英文名称: Monoclonal Antibody against Leukocyte Common Antigen
产品编号: SIG-3330
产品价格: null
产品产地: USA
品牌商标: COVANCE
更新时间: 2023-08-17T13:40:59
使用范围:
翌圣生物科技(上海)股份有限公司
- 联系人 : 李自转
- 地址 : 上海市浦东新区天雄路166弄一号楼三层南单元
- 邮编 : 200030
- 所在区域 : 上海
- 电话 : 139****5640
- 传真 : 021-34615995-188
- 邮箱 : lizizhuan@yeasen.com
Description | Monoclonal Antibody against Leukocyte Common Antigen (LCA) (Formerly Signet Catalog Nos: 330-01, 330-16 L1 Predilute, 330-26 L2 Predilute, 330-36 LV Predilute) | |
Intended Use | ** In Vitro Diagnostic (IVD) ** | |
Clone | 2B11 & PD7/26/16 | |
Form | Tissue Culture Supernatant (in 0.01M PBS + 0.1% NaN3 + 1% BSA) | |
Host | Mouse | |
Species Reactivity | Human | |
IsoType | IgG1 | |
Specificity | The Signet anti-LCA antibody recognizes a molecule present on the cell surface of human leukocytes. In combination, clones 2B11 and PD7/26/16 recognize four isoforms of LCA having molecular weights 180, 190, 205, and 220 kDa. Clone 2B11 was generated against cultured neoplastic cells from T cell lymphoma and clone PD7/26/16 was developed using human peripheral blood lymphocytes. Concentrated Format: SIG-3330-1000 [1 mL] Prediluted Formats: SIG-3330-16 [6 mL] is ready to use with Peroxidase Anti-Peroxidase detection systems such as Signet’s PAP (SIG-32140). SIG-3330-26 [6 mL] is ready-to-use with Biotin-based detection systems such as Signet's USA Ultrastreptavidin Detection (SIG-32250). SIG-3330-36 [6 mL] is ready-to-use with Biotin based detection systems on Ventana ES and Ventana NexES automated immunostainers. | |
Uses | This antibody is effective in immunohistochemistry (IHC). | |
Suggested Working Dilution | The optimal working dilution should be determined for each specific assay condition.
| |
Notes | Positive tissue (human): Tonsil or lymph node | |
Storage | Store between 2-8°C. | |
Warranty/Conditions | Covance products may not be resold or modified for resale without prior written approval. | |
Rev. Date | 4/3/2007 |